Diabetes Care 28:668-674, 2005
© 2005 by the American Diabetes Association, Inc.
Pathophysiology/Complications Original Article |
Diabetes, Glucose, Insulin, and Heart Rate Variability
The Atherosclerosis Risk in Communities (ARIC) study
Emily B. Schroeder, PHD1,
Lloyd E. Chambless, PHD2,
Duanping Liao, MD, PHD3,
Ronald J. Prineas, MD, PHD4,
Gregory W. Evans, MA4,
Wayne D. Rosamond, PHD5 and
Gerardo Heiss, MD, PHD5
1 Duke University School of Medicine, Duke University, Durham, North Carolina
2 Department of Biostatistics, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
3 Department of Health Evaluation Sciences, Pennsylvania State University College of Medicine, Hershey, Pennsylvania
4 Department of Public Health Sciences, Wake Forest School of Medicine, Wake Forest University, Winston-Salem, North Carolina
5 Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Address correspondence and reprint requests to Gerardo Heiss, MD, PhD, 137 E. Franklin St., Suite 306, Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514. E-mail: gerardo_heiss{at}unc.edu
OBJECTIVETo describe the progression of autonomic impairment among individuals with diabetes and pre-diabetic metabolic impairments.
RESEARCH DESIGN AND METHODSWe investigated the consequence of diabetes and pre-diabetic metabolic impairments on the 9-year change in heart rate variability (HRV) in a population-based cohort of 6,245 individuals aged 4564 years at baseline and cross-sectional associations among 9,940 individuals.
RESULTSDiabetic subjects had a more rapid temporal decrease in HRV conditional on baseline HRV than nondiabetic subjects. Adjusted mean annual changes (95% CI) (ms/year) in the SD of all normal-to-normal R-R intervals were 0.65 (0.69 to 0.61) for those with normal fasting glucose vs. 0.95 (1.09 to 0.81) for diabetic subjects, in root mean square of successive differences in normal-to-normal R-R intervals 0.35 (0.39 to 0.30) vs. 0.66 (0.82 to 0.51), and in R-R interval 6.70 (6.377.04) vs. 3.89 (2.725.05). While we found cross-sectional associations between decreased HRV and diabetes and nondiabetic hyperinsulinemia and a weak inverse association with fasting glucose, neither impaired fasting glucose nor nondiabetic hyperinsulimenia was associated with a measurably more rapid decline in HRV than normal.
CONCLUSIONSCardiac autonomic impairment appears to be present at early stages of diabetic metabolic impairment, and progressive worsening of autonomic cardiac function over 9 years was observed in diabetic subjects. The degree to which pre-diabetic metabolic impairments in insulin and glucose metabolism contribute to decreases in cardiac autonomic function remains to be determined.
Abbreviations: ARIC, Atherosclerosis Risk in Communities HF, high-frequency power HRV, heart rate variability IFG, impaired fasting glucose LF, low-frequency power NFG, normal fasting glucose rMSSD, root mean square of successive differences in normal-to-normal R-R intervals SDNN, SD of all normal-to-normal R-R intervals

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J.-S. Wu, Y.-C. Yang, T.-S. Lin, Y.-H. Huang, J.-J. Chen, F.-H. Lu, C.-H. Wu, and C.-J. Chang
Epidemiological Evidence of Altered Cardiac Autonomic Function in Subjects with Impaired Glucose Tolerance But Not Isolated Impaired Fasting Glucose
J. Clin. Endocrinol. Metab.,
October 1, 2007;
92(10):
3885 - 3889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Paterson, B. N. Rutledge, P. A. Cleary, J. M. Lachin, R. S. Crow, and for the Diabetes Control and Complications Trial/E
The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
Diabetes Care,
August 1, 2007;
30(8):
2107 - 2112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J. Suppl.,
June 1, 2007;
9(suppl_C):
C3 - C74.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J.,
January 1, 2007;
28(1):
88 - 136.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Kizilbash, M. R. Carnethon, C. Chan, D. R. Jacobs, S. Sidney, and K. Liu
The temporal relationship between heart rate recovery immediately after exercise and the metabolic syndrome: the CARDIA study
Eur. Heart J.,
July 1, 2006;
27(13):
1592 - 1596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Kreier, Y. S. Kap, T. C. Mettenleiter, C. van Heijningen, J. van der Vliet, A. Kalsbeek, H. P. Sauerwein, E. Fliers, J. A. Romijn, and R. M. Buijs
Tracing from Fat Tissue, Liver, and Pancreas: A Neuroanatomical Framework for the Role of the Brain in Type 2 Diabetes
Endocrinology,
March 1, 2006;
147(3):
1140 - 1147.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|